Nanostructured Lipid Carrier-Based Delivery of Pioglitazone for Treatment of Type 2 Diabetes

• Main Authors: Umair Ilyas (Author), Muhammad Asif (Author), Minglian Wang (Author), Reem Altaf (Author), Hajra Zafar (Author), Mirza Muhammad Faran Ashraf Baig (Author), Ana Cláudia Paiva-Santos (Author), Muhammad Abbas (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pioglitazone (PGZ) is utilized as a therapeutic agent in the management of (type 2) diabetes to control blood glucose levels. The existing research work was intended to make and optimize PGZ-containing NLCs (nanostructured lipid carriers). The fabricated nanostructured lipid carrier preparation was...